Researchers have confirmed previously identified recipient risk factors for early renal graft loss.
Women with a history of hypertensive pregnancy disorders (HPD), including preeclampsia, may be at increased risk for renal disease later in life.
Epoetin use and hemoglobin (Hb) levels have declined similarly for black and non-black dialysis patients following the advent of Medicare’s system of “bundled” payments.
Phosphate level is a stronger predictor for increased mortality among hemodialysis (HD) patients than calcium and parathyroid hormone (PTH) levels.
Metabolic syndrome (MetS) in patients with stage 3 and 4 CKD is associated with an increased risk of development of ESRD.
Patients with a failing kidney transplant are significantly less likely to receive vascular access surgery prior to starting HD than patients with advanced CKD.
Lanthanum carbonate acts in synergy with dietary phosphate restriction to decrease levels of fibroblast growth factor 23 (FGF-23) in patients with chronic kidney disease (CKD) and normal phosphate levels.